Empagliflozin, alone or in combination, in type 2 diabetes: Added benefit again not proven
Empagliflozin (trade name: Jardiance) has been approved since May 2014 for adults with type 2 diabetes mellitus in whom diet and exercise alone do not provide adequate glycaemic control. In 2014, the German Institute for ...
Jun 3, 2016
0
1